Divergent C-terminal motifs in Gα12 and Gα13 provide distinct mechanisms of effector binding and SRF activation.


Journal

Cellular signalling
ISSN: 1873-3913
Titre abrégé: Cell Signal
Pays: England
ID NLM: 8904683

Informations de publication

Date de publication:
08 2020
Historique:
received: 23 01 2020
revised: 19 04 2020
accepted: 19 04 2020
pubmed: 25 4 2020
medline: 4 8 2021
entrez: 25 4 2020
Statut: ppublish

Résumé

The G12/13 subfamily of heterotrimeric guanine nucleotide binding proteins comprises the α subunits Gα12 and Gα13, which transduce signals for cell growth, cytoskeletal rearrangements, and oncogenic transformation. In an increasing range of cancers, overexpressed Gα12 or Gα13 are implicated in aberrant cell proliferation and/or metastatic invasion. Although Gα12 and Gα13 bind non-redundant sets of effector proteins and participate in unique signalling pathways, the structural features responsible for functional differences between these α subunits are largely unknown. Invertebrates encode a single G12/13 homolog that participates in cytoskeletal changes yet appears to lack signalling to SRF (serum response factor), a transcriptional activator stimulated by mammalian Gα12 and Gα13 to promote growth and tumorigenesis. Our previous studies identified an evolutionarily divergent region in Gα12 for which replacement by homologous sequence from Drosophila melanogaster abolished SRF signalling, whereas the same invertebrate substitution was fully tolerated in Gα13 [Montgomery et al. (2014) Mol. Pharmacol. 85: 586]. These findings prompted our current approach of evolution-guided mutagenesis to identify fine structural features of Gα12 and Gα13 that underlie their respective SRF activation mechanisms. Our results identified two motifs flanking the α4 helix that play a key role in Gα12 signalling to SRF. We found the region encompassing these motifs to provide an interacting surface for multiple Gα12-specific target proteins that fail to bind Gα13. Adjacent to this divergent region, a highly-conserved domain was vital for SRF activation by both Gα12 and Gα13. However, dissection of this domain using invertebrate substitutions revealed different signalling mechanisms in these α subunits and identified Gα13-specific determinants of binding Rho-specific guanine nucleotide exchange factors. Furthermore, invertebrate substitutions in the C-terminal, α5 helical region were selectively disruptive to Gα12 signalling. Taken together, our results identify key structural features near the C-terminus that evolved after the divergence of Gα12 and Gα13, and should aid the development of agents to selectively manipulate signalling by individual α subunits of the G12/13 subfamily.

Identifiants

pubmed: 32330601
pii: S0898-6568(20)30130-3
doi: 10.1016/j.cellsig.2020.109653
pii:
doi:

Substances chimiques

Rho Guanine Nucleotide Exchange Factors 0
Serum Response Factor 0
GTP-Binding Protein alpha Subunits, G12-G13 EC 3.6.5.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109653

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Rebecca C Stecky (RC)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

Courtney R Quick (CR)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

Todd L Fleming (TL)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

Makenzy L Mull (ML)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

Vanessa K Vinson (VK)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

Megan S Whitley (MS)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

E Nicole Dover (EN)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America.

Thomas E Meigs (TE)

Department of Biology, University of North Carolina Asheville, One University Heights, Asheville, NC 28804, United States of America. Electronic address: tmeigs@unca.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH